Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
4,701
Views
8
CrossRef citations to date
0
Altmetric
Oncology
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer
Vladislav Berdunova PHMR Ltd, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-5743-2184View further author information
Steve Millenb Exact Sciences, London, UKView further author information
, Andrew Paramoreb Exact Sciences, London, UK
https://orcid.org/0000-0003-4070-9017View further author information
Peter Hallc Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK
https://orcid.org/0000-0001-6015-7841View further author information
Timothy Perrend Leeds Teaching Hospitals NHS Trust, Leeds, UKView further author information
, Rebecca Browna PHMR Ltd, London, UKView further author information
, Jane Griffine Jane Griffin Associates, East Molesey, UKView further author information
, Sarah Reyniab Exact Sciences, London, UKView further author information
, Nina Fryerb Exact Sciences, London, UKView further author information
& Louise Longwortha PHMR Ltd, London, UKView further author information
show all
Pages 591-604
|
Received 16 Mar 2022, Accepted 12 Apr 2022, Published online: 08 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.